Parallax Volatility Advisers, L.P. Kiniksa Pharmaceuticals, Ltd. Transaction History

Parallax Volatility Advisers, L.P.

  • $53.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$10.7 - $15.79 $85,364 - $125,972
7,978 New
7,978 $85,000
Q3 2021

Nov 15, 2021
SELL
$11.39 - $16.23 $188,914 - $269,190
-16,586 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$13.22 - $19.09 $137,606 - $198,707
10,409 Added 168.51%
16,586 $231,000
Q1 2021

May 14, 2021
BUY
$16.68 - $23.97 $103,032 - $148,062
6,177 New
6,177 $114,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $698M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email